Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
08/2008
08/05/2008US7407910 Ligands for asymmetric reactions
08/05/2008US7407516 variety of molecules used as oxidation bases and couplers allows a wide range of colors to be obtained; hair dye
08/05/2008CA2314514C Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents
07/2008
07/31/2008WO2008090731A1 Method for producing 2-nitroimidazole derivative
07/31/2008WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors
07/31/2008WO2007127010A3 Diarylthiohydantoin compounds
07/31/2008WO2007114946A3 Acid-sensitive linkers for drug delivery
07/31/2008US20080182993 chemical intermediate is 4-(3,5-bi (1,1- dimethylethyl-4-hydroxyphenyl)-N-methyl-2-thiazolemethylamine
07/31/2008US20080182885 Modified Azole Compounds As Antifungal and Antibacterial Agents
07/31/2008US20080182881 TNF-alpha production inhibitors
07/31/2008US20080181923 Dentifrices; stents; catheters; grafts
07/30/2008EP1950211A1 Process for production of cinnamamide derivative
07/30/2008CN101233146A Inhibitors of cancer cell, t-cell and keratinocyte proliferation
07/30/2008CN101233114A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors
07/30/2008CN101233113A Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation
07/30/2008CN101230041A Process and system of preparing ultra pure ionic liquids
07/30/2008CN100407493C 非水电解质和非水电解质二次电池 The non-aqueous electrolyte and a nonaqueous electrolyte secondary battery
07/30/2008CN100406466C Nucleic acid hydrolysis cutting agent based on cucurbituril
07/30/2008CN100406449C CDC25 phosphatase inhibitors
07/30/2008CN100406007C Asthma and allergic inflammation modulators
07/29/2008US7405233 e.g. 3-[3-(4-ISOPROPYLPHENYL)-2,5-DIOXO-IMIDAZOLIDIN-1-YL]-BENZOIC ACID SODIUM SALT; method of modulating premature translation termination and/or nonsense-mediated mRNA decay in a cell in vitro; cystic fibrosis or Duchenne muscular dystrophy
07/29/2008US7405229 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/29/2008CA2348742C Carbocyclic potassium channel inhibitors
07/29/2008CA2337755C Inhibitors of p38
07/29/2008CA2222936C Pesticidal sulfur compounds
07/29/2008CA2218702C Fatty acid esters as bioactive compounds
07/29/2008CA2168192C 4-aminobenzoylguanidine derivatives
07/24/2008WO2008089005A2 Renin inhibitors
07/24/2008WO2008086733A1 New pharmaceutical composition
07/24/2008WO2008065068A3 Substituted dihydroimidazoles and their use in the treatment of tumors
07/24/2008WO2007127473A3 Poly (ethylene glycol) containing chemically disparate endgroups
07/24/2008US20080177083 Trichomonas vaginalis infections and cecal amoeba infections; oral , intravenous and vaginal preparations; antiprotozoa agents; side effect reduction, nontoxic; superior to dextro-ornidazole and racemic ornidazole
07/24/2008US20080176919 Imidazole Derivatives As Enzyme Reverse Transcriptase Modulators
07/24/2008US20080176918 Adrenergic stimulant; 4-[1-(2,3-dimethyl-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione; hypertension, glaucoma, spasticity, pain, attention deficit disorder
07/24/2008US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders
07/24/2008US20080176862 New Compounds 617
07/24/2008US20080176859 Heterocyclyamide-substituted imidazoles
07/24/2008US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability
07/24/2008US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus
07/23/2008EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
07/23/2008EP1389223B1 Method for producing polyisocyanates
07/23/2008EP1073638B1 Heterocyclically substituted amides, their production and their use
07/23/2008EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
07/23/2008CN101228140A Imidazole-amino acid derivatives and related compounds synthetic method
07/23/2008CN101228116A Benzoyl-substituted serineamides
07/23/2008CN101225073A Ionic liquid as well as preparation method and its use in biological transesterification synthesis
07/23/2008CN100404515C Method for the production of purified 1,3-substituted imidazolium salts
07/23/2008CN100404514C 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use
07/23/2008CN100404513C 2-substituted-4,4,5,5-tetramethyl-1-oxyimidazoline, and its synthesis and use
07/22/2008US7402704 Arylsulfones and uses related thereto
07/22/2008US7402602 Imidazole derivatives modulating the sodium channels
07/22/2008US7402600 Nitroderivatives of cardiovascular agents
07/22/2008US7402579 Quinobenzoxazine analogs and compositions
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/22/2008CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
07/17/2008WO2008086131A1 Naphthylmethylimidizoles as therapeutic agents
07/17/2008WO2008084057A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
07/17/2008WO2008042282B1 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators
07/17/2008US20080171883 Solventless One-Step Process for the Production of Imidazole-2-thiones
07/17/2008US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors
07/17/2008US20080171881 Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton
07/17/2008US20080171863 Reacting fluorine salt containing radioactive fluorine-18 with alkyl halide or alkyl sulfonate in presence of alcohol; decreased reaction time; high yield; reduces the formation of side products
07/17/2008US20080171692 Substituted amides
07/17/2008CA2671554A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
07/16/2008EP1943235A1 Arylurea derivatives as modulators of chemokine receptor activity
07/16/2008EP1943228A2 Inhibitors of viral replication
07/16/2008EP1943227A1 Novel beta-agonists, process for their preparation and their use as medicaments
07/16/2008EP1942899A2 Mitotic kinesin inhibitors
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008CN101223252A Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks
07/16/2008CN101223134A Derivatives of seleno-amino acids
07/16/2008CN101222922A Diarylhydantoin compounds
07/16/2008CN101220046A Prochloraz derivant and application as fungicide thereof
07/16/2008CN101220033A Synthesis of temozolomide and analogs
07/16/2008CN101219995A Ion liquid based on heteropoly acid and synthesis thereof
07/16/2008CN101219994A Ozagrel ester, composition and production method thereof
07/16/2008CN100402505C Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/16/2008CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia
07/15/2008US7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
07/15/2008US7399854 Regents labeled with energy transfer dyes
07/15/2008US7399778 by targeting beta and gamma secretase enzyme decreases production of amyloid precursor protein; 5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide; Alzheimer's Disease, Down's Syndrome, cognitive decline
07/15/2008US7399775 β-amyloid protein production/secretion inhibitor
07/15/2008US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride
07/10/2008US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders
07/10/2008US20080166593 Organic Electroluminescent Devices
07/10/2008US20080166243 Liquid for Compressing a Gaseous Medium and Use of the Same
07/09/2008EP1942101A1 Secretase inhibitor
07/09/2008EP1940822A1 Imidazole derivatives and their use for modulating the gaba-a receptor complex
07/09/2008EP1940820A1 Midazole-4-carboxamide derivatives for use as cb modulators
07/09/2008EP1940814A1 Piperazine derivatives as antimalarial agents
07/09/2008EP1940803A1 1,2-diarylimidazoles for use as cbi modulators
07/09/2008EP1940802A2 Imidazole compounds for the treatment of neurological disorders
07/09/2008EP1940801A2 Imidazole derivatives and their use for modulating the gaba-a receptor complex
07/09/2008EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008EP1379496B1 Sulphones which modulate the action of gamma secretase
07/09/2008CN101218203A Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the ss2 adrenergic receptor
07/09/2008CN101215330A Method for preparing 1-aminohydantoin artificial antigen
07/09/2008CN101215263A Preparation of catalyst CRBA used for biodegradation polymer synthesis
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 345